333 Maternally Derived Antibodies Against RSV
نویسندگان
چکیده
منابع مشابه
Follow Up of Maternally Derived Antibodies Titer against Economically Important Viral Diseases of Chicken
The study was conducted to know the rate of maternally derived antibodies (MDAs) transfer from parents to their offspring and declining the MDAs in their chicks at 0, 7, 14, and 21 days of age against four major poultry viruses like Newcastle disease virus (NDV), Infectious bronchitis virus (IBV), Infectious bursal diseases virus (IBDV), and Avian Reo virus (ARV). The MDAs was studied on Grandp...
متن کاملCorrelation between neonatal calf diarrhea and the level of maternally derived antibodies
Passively acquired antibodies through colostrum will protect calves against etiological agents of neonatal calf diarrhea. Among them enteric diseases due to strains of Enterotoxigenic Escherichia coli (ETEC) are the most commonly occurring form of colibacillosis in newborn calves. Specific antibodies against whole ETEC cells and total immunoglobulin G in dam serum, colostrum and calf serum were...
متن کاملDuration of maternally derived antibodies against Akabane virus in calves: survival analysis.
To prevent encephalomyelitis caused by Akabane virus, as observed in 2006, vaccination of calves is one of the most effective prophylactic measures. For vaccination of calves, the duration of the maternal antibodies need to be considered because these antibodies are an obstacle to the effectiveness of the vaccine. In order to estimate the age of antibody decay in calves and to find factors infl...
متن کاملDiscovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants, the elderly and in immunosuppressed populations. The vast majority of neutralizing antibodies isolated from human subjects target the RSV fusion (F) glycoprotein, making it an attractive target for the development of vaccines and therapeutic antibodies. Currently, Synagis® (palivizumab) is the ...
متن کاملVaccination against RSV
The respiratory syncytial virus (RSV) is the major cause of lower respiratory tract illness (LRI) in infants worldwide. Also persons with heart/lung disease or an immunodeficiency disorder, and the elderly are at increased risk for severe LRI upon RSV infection. Although there is at present no licensed RSV vaccine available, it is a priority target for several vaccine developers. For the implem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1994
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199407000-00333